Syneron Medical, an Israeli-based company, recently received FDA approval to market LipoLite, a new, minimally invasive laser-assisted machine in which laser heats, destroys and coagulates subdermal tissue.

LipoLite causes fat cells to break apart and be eliminated by the body through non-selective heating of the adipose tissue. The 1064nm Nd:YAG laser energy is delivered via an optical fiber inside a cannula, inserted through a tiny incision to the treatment site. The thermal energy has the added advantage of tissue tightening via simultaneous photo-stimulation of dermal collagen.

Other pluses: Due to the coagulation properties of Nd:YAG lasers, there is less bruising or bleeding as compared to traditional liposuction for faster recovery. And as a complementary procedure, LipoLite can treat smaller areas not possible with liposuction.

LipoLite requires only local anesthetic and is designed to provide patients lasting results with little downtime and a high level of safety. The system is comfortable to use, upgradeable to support applications and fits easily on tabletops to save floor space in small operating rooms where space can be at a premium.